Authors : Karra Geetha; G Sasanka; Meraj Unnisa Banu; S. Pridvineel Reddy; T. Rama Rao

Volume/Issue : Volume 10 - 2025, Issue 3 - March

Google Scholar : https://tinyurl.com/343cuxx2

Scribd : https://tinyurl.com/4zjhkaf8

DOI : https://doi.org/10.38124/ijisrt/25mar1114

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.

Abstract : Long-term use of prescription and over-the-counter medications can lead to both subclinical and clinically significant micronutrient deficiencies, often developing gradually over time. Despite the widespread use of medications, research on drug-nutrient interactions remains limited. This review explores the potential effects of commonly prescribed drugs on nutrient absorption, metabolism, and utilization. Medications such as proton pump inhibitors (PPIs), non- steroidal anti-inflammatory drugs (NSAIDs), metformin, diuretics, ACE inhibitors, and bronchodilators can contribute to deficiencies in essential vitamins and minerals, including B12, calcium, magnesium, and iron. Pharmacists play a crucial role in identifying these interactions, monitoring at-risk individuals, and providing guidance on supplementation and dietary adjustments to prevent deficiencies. For instance, patients using PPIs may require B12 and calcium supplementation, while NSAID users may need iron due to a higher risk of anaemia. Likewise, diuretics necessitate regular monitoring of potassium and magnesium levels, whereas ACE inhibitors may require monitoring of potassium and zinc. While routine supplementation is not generally recommended, pharmacists help ensure adequate nutrient intake through diet and targeted supplementation when necessary. This review highlights the essential role of pharmacists in optimizing drug therapy and maintaining nutritional balance, ultimately improving patient health by reducing drug-induced nutrient deficiencies.

Keywords : Drug - Nutrient Interaction, Pharmacist-Led Interventions, Nutrient Deficiencies.

References :

1. McCabe BJ. Prevention of food-drug interactions with special emphasis on older adults. Current Opinion in Clinical Nutrition & Metabolic Care. 2004 Jan 1;7(1):21-6.
2. Mohn ES, Kern HJ, Saltzman E, Mitmesser SH, McKay DL. Evidence of drug–nutrient interactions with chronic use of commonly prescribed medications: An update. Pharmaceutics. 2018 Mar 20;10(1):36.3. Roe, D. Diet and Drug Interactions; Springer: New York, NY, USA, 1989; ISBN 978-94-011-6047-6.
3. Santos CA, Boullata JI. An approach to evaluating drug‐nutrient interactions. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2005 Dec;25(12):1789-800.5. Mason, P. Important drug-nutrient interactions. Proc. Nutr. Soc. 2010, 69, 551–557. [CrossRef] [PubMed]
4. Prescott JD, Drake VJ, Stevens JF. Medications and micronutrients: identifying clinically relevant interactions and addressing nutritional needs. Journal of Pharmacy Technology. 2018 Oct;34(5):216-30.
5. White R, Ashworth A. How drug therapy can affect, threaten and compromise nutritional status. Journal of human nutrition and dietetics. 2000 Apr;13(2):119-29.
6. Ashman JJ, Rui P, Schappert SM. Age differences in visits to office-based physicians by adults with hypertension: United States, 2013. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2016 Nov 1.
7. Balasubramanian BA, Marino M, Cohen DJ, Ward RL, Preston A, Springer RJ, Lindner SR, Edwards S, McConnell KJ, Crabtree BF, Miller WL. Use of quality improvement strategies among small to medium-size US primary care practices. The Annals of Family Medicine. 2018 Apr 1;16(Suppl 1):S35-43.
8. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. Jama. 2013 Dec 11;310(22):2435-42.
9. Ruscin JM, Lee Page R, Valuck RJ. Vitamin B12 deficiency associated with histamine2-receptor antagonists and a proton-pump inhibitor. Annals of Pharmacotherapy. 2002 May;36(5):812-6.
10. Metz, D.C., Sostek, M.B., Ruszniewski, P., Forsmark, C.E., Monyak, J. and Pisegna, J.R., 2007. Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. Official journal of the American College of Gastroenterology| ACG, 102(12), pp.2648-2654.
11. McColl KE. Effect of proton pump inhibitors on vitamins and iron. Official journal of the American College of Gastroenterology| ACG. 2009 Mar 1;104:S5-9.
12. Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. Southern medical journal. 2004 Sep 1;97(9):887-90.
13. Andersen BN, Johansen PB, Abrahamsen B. Proton pump inhibitors and osteoporosis. Current opinion in rheumatology. 2016 Jul 1;28(4):420-5.
14. Basu TK. Vitamin C-aspirin interactions. International Journal for Vitamin and Nutrition Research. Supplement= Internationale Zeitschrift Fur Vitamin-und Ernahrungsforschung. Supplement. 1982 Jan 1;23:83-90.
15. Konturek PC, Kania J, Hahn EG, Konturek JW. Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase. Journal of Physiology and Pharmacology. 2006 Nov 1;57:125.
16. Hammerman-Rozenberg R, Jacobs JM, Azoulay D, Stessman J. Aspirin prophylaxis and the prevalence of anaemia. Age and ageing. 2006 Sep 1;35(5):514-7.
17. Silagy CA, McNeil JJ, Donnan GA, Tonkin AM, Worsam B, Campion K. Adverse effects of low‐dose aspirin in a healthy elderly population. Clinical Pharmacology & Therapeutics. 1993 Jul;54(1):84-9.
18. Kim J, Ahn CW, Fang S, Lee HS, Park JS. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine. 2019 Nov 1;98(46):e17918.
19. Kang D, Yun JS, Ko SH, Lim TS, Ahn YB, Park YM, Ko SH. Higher prevalence of metformin-induced vitamin B12 deficiency in sulfonylurea combination compared with insulin combination in patients with type 2 diabetes: a cross-sectional study. PLoS One. 2014 Oct 9;9(10):e109878.
20. Raizada N, Jyotsna VP, Sreenivas V, Tandon N. Serum vitamin B12 levels in type 2 diabetes patients on metformin compared to those never on metformin: a cross-sectional study. Indian journal of endocrinology and metabolism. 2017 May 1;21(3):424-8.
21. Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger Van Der Burg B, Donker AJ, Stehouwer CD. Effects of short‐term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo‐controlled trial. Journal of internal medicine. 2003 Nov;254(5):455-63.
22. Khattab R, Albannawi M, Alhajjmohammed DA, Alkubaish Z, Althani R, Altheeb L, Ayoub H, Mutwalli H, Altuwajiry H, Al-Sheikh R, Purayidathil T. Metformin-induced vitamin B12 deficiency among type 2 diabetes mellitus' patients: A systematic review. Current diabetes reviews. 2023 May 1;19(4):1-0.
23. Pankiv I. Association of B12 levels with metformin use in type 2 diabetes patients. InEndocrine Abstracts 2020 Aug 21 (Vol. 70). Bioscientifica.
24. Stier, C.T.; Itskovitz, H.D. Renal calcium metabolism and diuretics. Annu. Rev. Pharmacol. Toxicol. 1986, 26, 101–116.
25. Arrabal-Polo MA, Arias-Santiago S, de Haro-Muñoz T, Lopez-Ruiz A, Orgaz-Molina J, Gonzalez-Torres S, Zuluaga-Gomez A, Arrabal-Martin M. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis. Urology. 2013 Apr 1;81(4):731-7.
26. Wang J, Su K, Sang W, Li L, Ma S. Thiazide diuretics and the incidence of osteoporotic fracture: a systematic review and meta-analysis of cohort studies. Frontiers in Pharmacology. 2019 Nov 21;10:1364.
27. Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated with loop diuretics. Journal of internal medicine. 2006 Jan;259(1):117-24.
28. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. Journal of bone and mineral research. 2006 Jan 1;21(1):163-70.
29. Barron RL, Oster G, Grauer A, Crittenden DB, Weycker D. Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporosis International. 2020 Nov;31:2103-11.
30. Friedman PA, Bushinsky DA. Diuretic effects on calcium metabolism. InSeminars in nephrology 1999 Nov 1 (Vol. 19, No. 6, pp. 551-556).
31. Runolfsdottir HL, Sigurdsson G, Franzson L, Indridason OS. Gender comparison of factors associated with age-related differences in bone mineral density. Archives of osteoporosis. 2015 Dec;10:1-9.
32. Chandler PD, Scott JB, Drake BF, Ng K, Forman JP, Chan AT, Bennett GG, Hollis BW, Giovannucci EL, Emmons KM, Fuchs CS. Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D. The American journal of medicine. 2014 Aug 1;127(8):772-8.
33. McCabe-Sellers BJ, Sharkey JR, Browne BA. Diuretic medication therapy use and low thiamin intake in homebound older adults. Journal of Nutrition for the Elderly. 2005 Apr 15;24(4):57-71.
34. Katta N, Balla S, Alpert MA. Does long-term furosemide therapy cause thiamine deficiency in patients with heart failure? A focused review. The American Journal of Medicine. 2016 Jul 1;129(7):753-e7.
35. Suter PM, Vetter W. Diuretics and Vitamin B: Are Diuretics a Risk Factor for Thiamin Malnutrition?. Nutrition reviews. 2000 Oct 1;58(10):319-23.
36. Nazmi A, Weatherall M, Wilkins B, Robinson GM. Thiamin concentration in geriatric hospitalized patients using frusemide. Journal of nutrition in gerontology and geriatrics. 2014 Jan 1;33(1):47-54.
37. Ware JS, Wain LV, Channavajjhala SK, Jackson VE, Edwards E, Lu R, Siew K, Jia W, Shrine N, Kinnear S, Jalland M. Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia. The Journal of clinical investigation. 2017 Sep 1;127(9):3367-74.
38. Ernst ME, Fravel MA. Thiazide and the thiazide-like diuretics: review of hydrochlorothiazide, chlorthalidone, and indapamide. American journal of hypertension. 2022 Jul 1;35(7):573-86.
39. Haddy FJ, Vanhoutte PM, Feletou M. Role of potassium in regulating blood flow and blood pressure. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2006 Mar;290(3):R546-52.
40. Takeda N, Takaoka T, Ueda C, Toda N, Kalubi B, Yamamoto S. Zinc deficiency in patients with idiopathic taste impairment with regard to angiotensin converting enzyme activity. Auris Nasus Larynx. 2004 Dec 1;31(4):425-8.
41. Suliburska J, Skrypnik K, Szulińska M, Kupsz J, Markuszewski L, Bogdański P. Diuretics, Ca-Antagonists, and angiotensin-converting enzyme inhibitors affect zinc status in hypertensive patients on monotherapy: a randomized trial. Nutrients. 2018 Sep 11;10(9):1284.
42. Stoltz ML, Andrews CE. Severe hyperkalemia during very-low-calorie diets and angiotensin converting enzyme use. JAMA. 1990 Dec 5;264(21):2737-8.
43. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation. 1993 Nov;88(5):2277-83.
44. Sivri A, Çöplü L. Effect of the long‐term use of inhaled corticosteroids on bone mineral density in asthmatic women. Respirology. 2001 Jun;6(2):131-4.
45. Etminan M, Sadatsafavi M, Zavareh SG, Takkouche B, FitzGerald JM. Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug safety. 2008 May;31:409-14.
46. Loke YK, Gilbert D, Thavarajah M, Blanco P, Wilson AM. Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis. BMJ open. 2015 Nov 1;5(11):e008554.
47. Chalitsios CV, Shaw DE, McKeever TM. Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies. Thorax. 2021 Jan 1;76(1):21-8.
48. Agarwal, R. (2015). Diuretics and electrolyte imbalance. Nephrology, Dialysis, Transplantation, 30(2), 65-71.
49. Bauman, W. A., Shaw, S., & Purnell, J. (2009). Increased intake of vitamin B12: Potential utility in metformin therapy. Diabetes Care, 32(6), 1024-1030.
50. Ferry, P. (2021). ACE inhibitors and zinc deficiency. Journal of Hypertension, 39(12), 2319-2323.
51. Messaoudi, M. (2015). The interaction of proton pump inhibitors with magnesium and calcium absorption. Journal of Gastroenterology, 50(3), 209-214.
52. Scholten, R., Simonet, C., & Fischer, D. (2015). Inhaled corticosteroids and their effects on bone mineral density: A clinical review. Journal of Bone and Mineral Research, 30(11), 1933-1943.
53. Vidal, R., & Blanchard, H. (2018). NSAIDs and iron deficiency anemia: A review of gastrointestinal blood loss and supplementation therapy. Hematology Research and Practice, 1(2), 122-127.